Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers
- PMID: 27811119
- PMCID: PMC5336397
- DOI: 10.1158/1055-9965.EPI-16-0496
Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers
Abstract
Background: People with germline mutation in one of the DNA mismatch repair (MMR) genes have increased colorectal cancer risk. For these high-risk people, study findings of the relationship between alcohol consumption and colorectal cancer risk have been inconclusive.Methods: 1,925 MMR gene mutations carriers recruited into the Colon Cancer Family Registry who had completed a questionnaire on lifestyle factors were included. Weighted Cox proportional hazard regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association between alcohol consumption and colorectal cancer.Results: Colorectal cancer was diagnosed in 769 carriers (40%) at a mean (SD) age of 42.6 (10.3) years. Compared with abstention, ethanol consumption from any alcoholic beverage up to 14 g/day and >28 g/day was associated with increased colorectal cancer risk (HR, 1.50; 95% CI, 1.09-2.07 and 1.69; 95% CI, 1.07-2.65, respectively; Ptrend = 0.05), and colon cancer risk (HR, 1.78; 95% CI, 1.27-2.49 and 1.94; 95% CI, 1.19-3.18, respectively; Ptrend = 0.02). However, there was no clear evidence for an association with rectal cancer risk. Also, there was no evidence for associations between consumption of individual alcoholic beverage types (beer, wine, spirits) and colorectal, colon, or rectal cancer risk.Conclusions: Our data suggest that alcohol consumption, particularly more than 28 g/day of ethanol (∼2 standard drinks of alcohol in the United States), is associated with increased colorectal cancer risk for MMR gene mutation carriers.Impact: Although these data suggested that alcohol consumption in MMR carriers was associated with increased colorectal cancer risk, there was no evidence of a dose-response, and not all types of alcohol consumption were associated with increased risk. Cancer Epidemiol Biomarkers Prev; 26(3); 366-75. ©2016 AACR.
©2016 American Association for Cancer Research.
Conflict of interest statement
The authors have no conflict of interest to declare with respect to this manuscript.
Figures
References
-
- Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of Lynch syndrome: 1895–2015. Nat Rev Cancer. 2015;15:181–94. - PubMed
-
- Bonadona V, Bonaiti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011;305:2304–10. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HHSN261201000140C/CA/NCI NIH HHS/United States
- U01 CA074799/CA/NCI NIH HHS/United States
- U24 CA074794/CA/NCI NIH HHS/United States
- N01 PC035142/CA/NCI NIH HHS/United States
- UM1 CA167551/CA/NCI NIH HHS/United States
- U58 DP003862/DP/NCCDPHP CDC HHS/United States
- U01 CA074783/CA/NCI NIH HHS/United States
- U24 CA074799/CA/NCI NIH HHS/United States
- U24 CA074783/CA/NCI NIH HHS/United States
- N01 CN067009/CN/NCI NIH HHS/United States
- U24 CA074806/CA/NCI NIH HHS/United States
- HHSN261201300009I/CA/NCI NIH HHS/United States
- N01 PC035137/CA/NCI NIH HHS/United States
- HHSN261201300009C/CA/NCI NIH HHS/United States
- U24 CA097735/CA/NCI NIH HHS/United States
- U01 CA074794/CA/NCI NIH HHS/United States
- HHSN261201300011C/RC/CCR NIH HHS/United States
- HHSN261201300012I/CA/NCI NIH HHS/United States
- HHSN261201300021C/CA/NCI NIH HHS/United States
- P30 CA015083/CA/NCI NIH HHS/United States
- HHSN261201000035I/CA/NCI NIH HHS/United States
- HHSN261201000035C/PC/NCI NIH HHS/United States
- HHSN261201000034C/CA/NCI NIH HHS/United States
- U01 CA097735/CA/NCI NIH HHS/United States
- U01 CA074806/CA/NCI NIH HHS/United States
- U24 CA074800/CA/NCI NIH HHS/United States
- P30 CA071789/CA/NCI NIH HHS/United States
- HHSN261201000121C/CP/NCI NIH HHS/United States
- U01 CA074800/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
